EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

VEXAS‐Syndrome, a newly described autoinflammatory systemic disease with dermatologic manifestations

Vera Baur, Johanna Stoevesandt, Axel Hueber, Ulrike Hüffmeier, Hermann Kneitz, Henner Morbach, Erwin Schultz, Matthias Goebeler

JDDG: Journal der Deutschen Dermatologischen Gesellschaft · 2023

DOI: 10.1111/ddg.15227 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2023. Verfasst von Vera Baur und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Paracelsus Medical Private University, Nuremberg, Germany. Hauptthemen laut MEDLINE: Cartilage Diseases, Ear Auricle, Autoimmune Diseases, Sweet Syndrome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

VEXAS syndrome is a recently identified autoinflammatory systemic disease caused by an acquired somatic mutation of the X‐linked UBA1 gene, the key enzyme of the first step of ubiquitylation. The acronym VEXAS stands for the characteristics Vacuoles , E1 enzyme , X‐linked , autoinflammatory and somatic . The disease occurs in advanced adulthood preferentially in men and is characterized by hematological, rheumatological and dermatological symptoms. The latter include neutrophil‐rich lesions reminiscent of Sweet's syndrome, erythema nodosum‐ and panniculitis‐like skin manifestations and recurrent polychondritis of the nose and auricles. The presence of cytoplasmic vacuoles in myeloid and erythroid precursors in the bone marrow is characteristic. In up to half of the cases, VEXAS syndrome is associated with myelodysplastic syndrome. Dermatologists should be familiar with the clinical picture, as skin symptoms are often the first indicator of the disease. Molecular diagnostics are essential for confirming the diagnosis and risk stratification of affected patients. In this minireview we provide an overview of the pathophysiology, diagnosis and therapy of VEXAS syndrome and illustrate its clinical picture with two own cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cartilage DiseasesEar AuricleAutoimmune DiseasesSweet SyndromeMaleMutationHumansMyelodysplastic SyndromesAdultSkin Diseases, Genetic

Autor:innen und Institutionen

  • Department of Dermatology, Paracelsus Medical Private University, Nuremberg, Germany.
  • Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany.
  • Department of Rheumatology, Paracelsus Medical Private University, Nuremberg, Germany.
  • Institute of Human Genetics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
  • Department of Pediatrics, University Hospital Würzburg, Würzburg, Germany.

Zitieren

APA

Baur, V., Stoevesandt, J., Hueber, A., Hüffmeier, U., Kneitz, H., Morbach, H., Schultz, E., & Goebeler, M. (2023). VEXAS‐Syndrome, a newly described autoinflammatory systemic disease with dermatologic manifestations. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. https://doi.org/10.1111/ddg.15227

Vancouver

Baur V, Stoevesandt J, Hueber A, Hüffmeier U, Kneitz H, Morbach H, et al. VEXAS‐Syndrome, a newly described autoinflammatory systemic disease with dermatologic manifestations. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2023. doi:10.1111/ddg.15227

BibTeX
@article{Baur2023,
  author = {Baur, Vera and Stoevesandt, Johanna and Hueber, Axel and Hüffmeier, Ulrike and Kneitz, Hermann and Morbach, Henner and Schultz, Erwin and Goebeler, Matthias},
  title = {VEXAS‐Syndrome, a newly described autoinflammatory systemic disease with dermatologic manifestations},
  journal = {JDDG: Journal der Deutschen Dermatologischen Gesellschaft},
  year = {2023},
  doi = {10.1111/ddg.15227}
}
Kostenlos starten →